Blog Posts

Join BioStorage Technologies at ISBER for Workshops, Poster Presentations, Interactive Discussions and a Fireworks Party!

The International Society for Biological and Environmental Repositories (ISBER) is a global biobanking community that supports the largest international forum for technical, legal, ethical and managerial issues relevant to repositories of biological and environmental specimens worldwide. The ISBER 2014 Annual Meeting takes place May 20-24 at Walt Disney World in Orlando, FL. This meeting will […]

Read more »

The Role of Technology in Advancing Pharmaceutical Drug Discovery and Development

Embracing Innovative Technologies The drug development industry is entering a new technology era that is filled with both opportunities and challenges. Due to an increasing array of cost-reduction, efficiency objectives and safety drivers from the commercial, regulatory and patient sectors –the likes of which have never been seen before – research organizations are embracing innovative […]

Read more »

Collaborative Partnerships that Optimize & Accelerate Pharmaceutical Drug Development

Smartsourcing = Value by Innovation It has been widely recognized that the global pharmaceutical industry is experiencing dynamic change. Under high pressure to contain fixed costs, many biopharmaceutical companies have reduced their internal staff and infrastructure capacities in drug R&D, manufacturing and other supporting functions, instead opting to outsource these functions. With the growing sophistication […]

Read more »

Biobanking Informatics: Transforming Biological Samples into Scientific & Financial Assets

Today, advancements in medical therapies rely heavily on a researcher’s ability to manage sample assets and to efficiently link clinical and laboratory data to collected samples. As a result, the need for a full-scale, computerized database that stores, organizes, indexes and analyzes samples and their associated data has become a critical component in the drug […]

Read more »

Sample Management Challenges and Opportunities in Asia Pacific

The Asia-Pacific region is home to over three billion people. With a combined total economy estimated at $20 trillion, five countries in the region -China, Japan, India, Australia and Korea- rank among the Top 15 largest economies in the world. As global biopharmaceutical companies continue to expand clinical trial research in Asia-Pacific, the need for […]

Read more »

Long-term Business Growth in China Depends on Collaboration

Conducting clinical trial research in China has become a top global strategic priority for many biopharmaceutical executives. Even though language and cultural barriers remain, transportation infrastructure is limited and the expectation for governmental scrutiny has increased, China is considered one of the world’s most attractive drug development markets, and the fastest-growing. Since 2006, 13 of […]

Read more »

Trends in Smartsourcing Biospecimen Resources

Today’s evolving world of biopharmaceutical drug discovery and development is moving rapidly toward harnessing the exciting opportunity of targeted medicine through the advancement of genomic research and biomarker development.  Cost-reductions in R&D budgets has been a key driver as research organizations seek to find ways of integrating sample asset inventories and bioprocessing methods to maximize […]

Read more »

The Value of Biorepository Accreditation by the College of American Pathologists

With more than 18,000 members, the College of American Pathologists (CAP) is the largest global association of board-certified pathologists, pathologists-in-training and lab personnel, and the second largest medical society in the United States, serving patients, physicians and the public with gold standard excellence in the practice of pathology and laboratory medicine. The Illinois-based organization pioneered […]

Read more »

Understanding How to Navigate the Regulatory Environment in China

As the world’s most populated country, the People’s Republic of China boasts a current population of 1.39 billion. This has led to the growing importance of healthcare and technology advancements within China. In 2012, China decided to invest in the technology sector as part of its current five-year economic plan, putting the biology, energy and […]

Read more »

Three Factors for Successful Sample Management Operations in China

With its established success in China, Charles River Laboratories has a solid research foundation which will be further enhanced by BioStorage Technologies’ expertise in global sample management. Charles River is, among many other things, a drug research and development company with a goal of delivering safe and effective therapies to patients around the world. Their […]

Read more »